NCT05528055: A Study to Investigate the Safety and Tolerability of SCR-6920 Capsule in Patients With Advanced Malignant Tumors |
|
|
| Recruiting | 1 | 122 | RoW | SCR-6920 capsule, PRMT5 inhibitor | Jiangsu Simcere Pharmaceutical Co., Ltd. | Solid Tumor, Non Hodgkin Lymphoma | 10/27 | 10/27 | | |